therapy

[키워드] 95% CI acute respiratory syndrome addition Admission admitted to ICU age Analysis Cancer Cardiopulmonary Chemotherapy chronic obstructive clinical Clinical characteristics Clinical outcome Cohort cohort study collaboration collected Comorbidities Comorbidity composed consecutive patient Cooperative coronavirus country Course COVID-19 COVID-19 diagnosis COVID-19 in patient criteria cross-sectional death demographics died eight eligible epithelial feature finding Follow-up funding General population global pandemic group high mortality high mortality rate histology hospitalised hypertension ICU admission increased risk Infection intensive care International Laboratory lung cancer Lung imaging majority median age medical record Mortality multicentre multivariable analysis multivariable logistic regression Neoplasms neuroendocrine Odds ratio Older Older age outcome pandemic Patient patient data patients Patients with cancer patients with COVID-19 performance status Pneumonia pulmonary disease receiving reduced RT-PCR SARS-CoV-2 Sex smoker smoking smoking status suggested susceptible Symptom Symptoms therapeutic options therapy Thoracic Thoracic malignancies Thoracic malignancy thought thymic Treatment Tumours univariable were measured WHO with COVID-19
[DOI] 10.1016/S1470-2045(20)30314-4 [Article Type] Research article